Beta Blocker Management Post MI: Navigating Continuation and Interruption Strategies

Uncategorized

Beta Blocker Management Post MI: Navigating Continuation and Interruption Strategies
Authors:-Bhupathi Sravani, Sirasani Tapaswi

Abstract-This study examines the effects of interrupting versus continuing beta-blocker therapy in post-myocardial infarction patients. The ABYSS trial, a multicenter noninferiority study, found that interrupting beta-blocker therapy did not offer any advantages over continuation in reducing major cardiovascular events or improving quality of life. The interruption group experienced a slight increase in hospitalizations for coronary-related conditions. These findings challenge existing guidelines recommending beta-blocker discontinuation after one year for certain patients. The trial highlights the necessity for additional research to clarify the role of beta-blockers in modern post-MI care, especially for patients with preserved left ventricular function.

DOI: 10.61137/ijsret.vol.11.issue1.142

× How can I help you?